Private Capital Management (Colorado)’s TransCode Therapeutics RNAZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-87	Closed	-$46.1K	–	267
2024 Q3	$46.1K	Buy	87 +68	+358%	+$36K	0.01%	231
2024 Q2	$17.6K	Buy	+19	New	+$17.6K	﹤0.01%	215